PDIA2 and malignant colon neoplasm: To explore the association of PDIA2 overexpression with the changes of cellular signaling pathways in response to AOM/DSS treatment, PDIA2-interacting proteins in HT29 colon cancer cells were detected by PDIA2 coimmunoprecipitation (CO-IP)–mass spectrum analysis.